Date: 18.12.2013
Forest geneticists at Oregon State University have created genetically modified poplar trees that grow faster, have resistance to insect pests and are able to retain expression of the inserted genes for at least 14 years, a report in the Canadian Journal of Forest Research.
The trees are one of the best successes to date in the genetic modification of forest trees, a field that is much less advanced than GMO products in crop agriculture. The advance could prove especially useful in the paper and pulp industries, and in an emerging biofuel industry that could be based on hybrid poplar plantations.
Commercial use of such trees could be done with poplars that also had been engineered to be sterile so they would be unlikely to spread their characteristics to other trees, researchers said.
"In terms of wood yield, plantation health and productivity, these GMO trees could be very significant," said Steven Strauss, a distinguished professor of forest biotechnology in the OSU College of Forestry. "Our field experiments and continued research showed results that exceeded our expectations. And it is likely that we have underestimated the value these trees could have in improved growth and production."
Some genetically modified hybrid poplar trees are already being used commercially in China, but none in the United States. The use of GMO trees in the U.S. still faces heavy regulatory obstacles, Strauss said. Agencies are likely to require extensive studies of gene flow and their effects on forest ecosystems, which are difficult to carry out, he said.
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
This website is maintained by: CREOS CZ
© 2006 - 2024 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
Biotechnology organizations - Biotech research institute, company, university, ..
Biotechnology - Biotechnology channel at Nature.com
Using a parasite pest to create bioluminescent wood
Microrobot-packed pill shows promise for treating inflammatory bowel disease in mice